Squamous cell carcinoma (SCC) is a type of skin cancer that affects millions of people around the world every year. It is one of the most common types of skin cancer, and is usually caused by exposure to ultraviolet (UV) radiation from the sun. Although SCC is usually easily treated and cured, it can be deadly if not detected and treated early. As such, it is important for doctors to have a thorough understanding of SCC in order to diagnose and treat it effectively. This article will explore the journey of discovery into unlocking the secrets of SCC, and the progress that has been made in recent years.
SCC is a type of skin cancer that affects the squamous cells, which are the thin, flat cells that form the top layer of the skin. It is usually caused by exposure to UV radiation from the sun or other sources, such as tanning beds. It can also be caused by certain chemicals, such as arsenic, and can occur in people with weakened immune systems, such as those with HIV or AIDS. SCC can appear as a small, scaly patch on the skin, or as a raised, red bump. It may also appear as an open sore that does not heal. If left untreated, SCC can spread to other parts of the body and become life-threatening.
The diagnosis of SCC is typically based on a physical examination of the skin. The doctor may take a biopsy of the affected area to confirm the diagnosis. In some cases, imaging tests such as X-rays, CT scans, or MRI scans may be used to help diagnose SCC.
The treatment of SCC depends on the size, location, and stage of the cancer. Smaller SCCs can usually be treated with topical medications or cryotherapy, which uses extreme cold to destroy the cancer cells. Larger SCCs may require surgery to remove the cancer. In some cases, radiation therapy or chemotherapy may be used to treat SCC.
In recent years, researchers have made significant progress in understanding the underlying biology of SCC. This has led to the development of new treatments that are more effective and less invasive than traditional treatments. One of the major advances in SCC research has been the development of targeted therapies. These drugs are designed to target specific molecules or pathways in the cancer cells, which helps to reduce the side effects of treatment. For example, BRAF inhibitors are drugs that target the BRAF protein, which is found in many SCCs. These drugs have been shown to be effective in treating SCCs that are resistant to traditional treatments. Another important development has been the use of immunotherapy to treat SCC. Immunotherapy uses the body’s own immune system to fight the cancer. This approach has been successful in treating some SCCs that are resistant to traditional treatments.
Squamous cell carcinoma is a type of skin cancer that affects millions of people around the world every year. It is important for doctors to have a thorough understanding of SCC in order to diagnose and treat it effectively. In recent years, researchers have made significant progress in understanding the underlying biology of SCC, leading to the development of new treatments that are more effective and less invasive than traditional treatments. With continued research and advances in understanding the secrets of SCC, more effective treatments will be developed, allowing for better outcomes for patients.
1.
Approved BTK Inhibitor Without Covalent Bond for CLL.
2.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
3.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
4.
Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.
5.
Brain cancer: a Q&A session.
1.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
4.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
5.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation